Citadel Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-199,269
Closed -$650K 7074
2022
Q4
$650K Sell
199,269
-421
-0.2% -$1.37K ﹤0.01% 3619
2022
Q3
$587K Sell
199,690
-11,794
-6% -$34.7K ﹤0.01% 3929
2022
Q2
$520K Buy
211,484
+11,701
+6% +$28.8K ﹤0.01% 4095
2022
Q1
$1.62M Buy
199,783
+23,481
+13% +$190K ﹤0.01% 3245
2021
Q4
$2.35M Buy
176,302
+123,498
+234% +$1.64M ﹤0.01% 2885
2021
Q3
$2.3M Buy
52,804
+51,433
+3,751% +$2.24M ﹤0.01% 2840
2021
Q2
$57K Buy
+1,371
New +$57K ﹤0.01% 6169
2021
Q1
Sell
-2,524
Closed -$248K 7030
2020
Q4
$248K Buy
2,524
+1,792
+245% +$176K ﹤0.01% 4374
2020
Q3
$50K Buy
+732
New +$50K ﹤0.01% 4398
2020
Q2
Sell
-2,423
Closed -$215K 5524
2020
Q1
$215K Buy
2,423
+825
+52% +$73.2K ﹤0.01% 4037
2019
Q4
$183K Buy
1,598
+346
+28% +$39.6K ﹤0.01% 4160
2019
Q3
$77K Sell
1,252
-9,473
-88% -$583K ﹤0.01% 4302
2019
Q2
$837K Buy
10,725
+8,823
+464% +$689K ﹤0.01% 3127
2019
Q1
$256K Sell
1,902
-877
-32% -$118K ﹤0.01% 3822
2018
Q4
$223K Sell
2,779
-3,339
-55% -$268K ﹤0.01% 3788
2018
Q3
$643K Buy
6,118
+1,356
+28% +$143K ﹤0.01% 3010
2018
Q2
$476K Buy
4,762
+1,078
+29% +$108K ﹤0.01% 3165
2018
Q1
$464K Sell
3,684
-40,312
-92% -$5.08M ﹤0.01% 2964
2017
Q4
$7.35M Buy
43,996
+19,962
+83% +$3.33M ﹤0.01% 1096
2017
Q3
$7.57M Sell
24,034
-4,526
-16% -$1.43M 0.01% 1067
2017
Q2
$8.48M Buy
28,560
+1,424
+5% +$423K 0.01% 936
2017
Q1
$6.27M Buy
+27,136
New +$6.27M 0.01% 1106
2016
Q1
Sell
-1,044
Closed -$160K 4153
2015
Q4
$160K Buy
1,044
+825
+377% +$126K ﹤0.01% 3057
2015
Q3
$24K Buy
+219
New +$24K ﹤0.01% 3696